SOPHiA GENETICS SA

SOPH · NASDAQ

$6.93+$0.44 (+6.78%)TodayMarket closed ·
Prev close $6.49

About SOPH

SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. The company is headquartered in Rolle, Vaud and currently employs 415 full-time employees. The company went IPO on 2021-07-23. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The firm has offices in Switzerland, France, and the United States and operates worldwide.

Employees
415
Headquarters
Rolle, Vaud
Listed
Jul 23, 2021
Sector
Health Care
Industry
Health Care Technology

Leadership

SOPHiA GENETICS SA executives
NameTitleSince
Troy Cox——
Ross Muken——
Jurgi Camblong—2011
George Cardoza——
Manuela Da Silva Valente——
Zhenyu Xu——
Daan Van Well——
Philippe Menu—2023
Tomer Berkovitz——
Jean-Michel Cossiery——
Kathy Hibbs——
Didier Hirsch——
Vincent Ossipow——

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

SOPHiA GENETICS SA suppliers and customers
CompanyRelationshipCorrelation
Twist Bioscience TWSTSupplier—
IDT B IDTSupplier—
Hamilton Bonaduz AGSupplier—
General Electric GESupplier and customer—
Diagnosticos da America DASA3Customer—
Konica MinoltaSupplier and customer—
Microsoft MSFTSupplier—
Amazon.com AMZNSupplier—
PerkinElmer PKISupplier—
QIAGEN QGENSupplier—

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.